Last update 23 May 2025

B7H3 CAR T Cell(Seattle Children's Hospital)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Action
inhibitors
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD276 inhibitors(CD276 antigen inhibitors), Gene transference(Gene transference)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CarcinomaPhase 1
United States
13 Jul 2020
Clear Cell SarcomaPhase 1
United States
13 Jul 2020
Desmoplastic Small Round Cell TumorPhase 1
United States
13 Jul 2020
Ewing SarcomaPhase 1
United States
13 Jul 2020
HepatoblastomaPhase 1
United States
13 Jul 2020
MelanomaPhase 1
United States
13 Jul 2020
NeuroblastomaPhase 1
United States
13 Jul 2020
NeurofibrosarcomaPhase 1
United States
13 Jul 2020
RetinoblastomaPhase 1
United States
13 Jul 2020
Rhabdoid TumorPhase 1
United States
13 Jul 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
16
tnzuacxfbw(uhvgmyiigw) = xgwrasigcf qsrcencjoh (fpgahoqubm )
Positive
02 Jun 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free